Fundz

Gyala Therapeutics raised €3M in funding led by Invivo Partners, Nara Capital, and CDTI Innvierte. The funds will be used to expand operations and R&D efforts.

PRIVATESep 15, 2025

Amount Raised

€3 Million

Round Type

Funding Round

BarcelonaBiotechnologyHealth Care

Investors

CDTI InnvierteInvivo PartnersNara Capital

Description

Gyala Therapeutics, a Barcelona-based biotechnology company, raised €3M in funding. The company specializes in developing immunotherapies for hematological cancers. Backers included Invivo Partners, Nara Capital, and CDTI Innvierte. The funds will be used to expand operations and enhance R&D efforts.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Gyala Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Prelude raised $5M on October 30, 2025.
  • Surgical Automations raised $3.4M (Seed) on October 30, 2025.
  • Helex raised $3.5M (Seed) on October 30, 2025.
  • Sparrow BioAcoustics raised $10M (Funding Round) on October 29, 2025.
  • Rarity PBC raised $4.6M (Seed) on October 29, 2025.
  • PineTree Therapeutics raised $47M (Series B) on October 29, 2025.

Who to call at Gyala Therapeutics, and when

A new round usually means Gyala Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Gyala Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gyala Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gyala Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gyala Therapeutics

Location

Barcelona, Catalonia, Spain

About

Gyala Therapeutics is a spin off from Hospital Clínic – IDIBAPS (Barcelona) focused on developing new CAR-T therapies for treating hematological malignancies. We raised raised around €8 million to date through equity investment from Invivo Partners, Nara Capital, and CDTI Innvierte, as well as non-dilutive funding from national innovation programs including NEOTEC and Public-Private Collaboration Projects.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gyala Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Gyala Therapeutics's next move

See what Strategic adds

Gyala Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.